Last updated: 2026-09-06 21:47:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Icon Plc (ICLR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $164,81, with a market capitalization of $12,72B and a P/E ratio of 37,66. Over the past 52 weeks, its price has ranged from $66,57 to $203,91. This page covers its latest market performance, valuation, price trends and company information.
$12,72B | |
$159,94 | |
$347,72 | |
$0,03 | |
$163,58 | |
675,10K | |
804,64K | |
37,66 | |
$203,91 | |
$66,57 | |
-- | |
-- |
Icon Plc (ICLR) last closed at $163,58 as of 2026-09-04 23:31:00, unchanged from the previous close of $163,58.
During the latest regular trading session, ICLR traded between $0,03 and $347,72, with a volume of 675,10K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Icon Plc (ICLR) moved from $169,72 to $164,81, representing a decline of 2,89% ($4,91).
The stock traded between $158,37 and $174,12 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 612,42 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 71,5%
ICLR is currently trading at $164,81, placing it 71,5% of the way from its 52-week low of $66,57 to its 52-week high of $203,91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
| Employees | 40100 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Icon Plc (ICLR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.